Diagnosis and management of precocious sexual maturation: an updated review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Livadas S, Chrousos GP (2019) Molecular and environmental mechanisms regulating puberty initiation: an integrated approach. Front Endocrinol (Lausanne) 10:828. https://doi.org/10.3389/fendo.2019.00828
de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 100:10972–10976. https://doi.org/10.1073/pnas.1834399100
Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM (2005) Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci U S A 102:2129–2134. https://doi.org/10.1073/pnas.0409822102
Bianco SD (2012) A potential mechanism for the sexual dimorphism in the onset of puberty and incidence of idiopathic central precocious puberty in children: sex-specific kisspeptin as an integrator of puberty signals. Front Endocrinol (Lausanne) 3:149. https://doi.org/10.3389/fendo.2012.00149
Brito VN, Spinola-Castro AM, Kochi C, Kopacek C, Silva PC, Guerra-Júnior G (2016) Central precocious puberty: revisiting the diagnosis and therapeutic management. Arch Endocrinol Metab 60:163–172. https://doi.org/10.1590/2359-3997000000144
Abreu AP, Kaiser UB (2016) Pubertal development and regulation. Lancet Diabetes Endocrinol 4:254–264. https://doi.org/10.1016/S2213-8587(15)00418-0
Lanciotti L, Cofini M, Leonardi A, Penta L, Esposito S (2018) Up-to-date review about minipuberty and overview on hypothalamic-pituitary-gonadal axis activation in fetal and neonatal life. Front Endocrinol (Lausanne) 9:410. https://doi.org/10.3389/fendo.2018.00410
Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291–303. https://doi.org/10.1136/adc.44.235.291
Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13–23. https://doi.org/10.1136/adc.45.239.13
Carel JC, Léger J (2008) Clinical practice. Precocious puberty. N Engl J Med 358:2366–2377. https://doi.org/10.1056/NEJMcp0800459
Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP (2003) The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 24:668–693. https://doi.org/10.1210/er.2002-0019
Bradley SH, Lawrence N, Steele C, Mohamed Z (2020) Precocious puberty. BMJ 368:l6597. https://doi.org/10.1136/bmj.l6597
Sørensen K, Mouritsen A, Aksglaede L, Hagen CP, Mogensen SS, Juul A (2012) Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty. Horm Res Paediatr 77:137–145. https://doi.org/10.1159/000336325
Soriano-Guillén L, Argente J (2019) Central precocious puberty, functional and tumor-related. Best Pract Res Clin Endocrinol Metab 33:101262. https://doi.org/10.1016/j.beem.2019.01.003
Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, Hasemeier CM (1997) Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 99:505–512. https://doi.org/10.1542/peds.99.4.505
Kaplowitz PB, Oberfield SE (1999) Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 104:936–941. https://doi.org/10.1542/peds.104.4.936
Latronico AC, Brito VN, Carel JC (2016) Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol 4:265–274. https://doi.org/10.1016/S2213-8587(15)00380-0
Partsch CJ, Sippell WG (2001) Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens. Hum Reprod Update 7:292–302. https://doi.org/10.1093/humupd/7.3.292
Teilmann G, Pedersen CB, Jensen TK, Skakkebaek NE, Juul A (2005) Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics 116:1323–1328. https://doi.org/10.1542/peds.2005-0012
Kim SH, Huh K, Won S, Lee KW, Park MJ (2015) A significant increase in the incidence of central precocious puberty among Korean girls from 2004 to 2010. Gonzalez-Bulnes A, editor. PLoS One 10:e0141844. https://doi.org/10.1371/journal.pone.0141844
Soriano-Guillén L, Corripio R, Labarta JI, Cañete R, Castro-Feijóo L, Espino R, Argente J (2010) Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration. J Clin Endocrinol Metab 95:4305–4313. https://doi.org/10.1210/jc.2010-1025
Aguirre RS, Eugster EA (2018) Central precocious puberty: from genetics to treatment. Best Pract Res Clin Endocrinol Metab 32:343–354. https://doi.org/10.1016/j.beem.2018.05.008
Chalumeau M, Chemaitilly W, Trivin C, Adan L, Bréart G, Brauner R (2002) Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities. Pediatrics 109:61–67. https://doi.org/10.1542/peds.109.1.61
Yoon JS, So CH, Lee HS, Lim JS, Hwang JS (2018) Prevalence of pathological brain lesions in girls with central precocious puberty: possible overestimation? J Korean Med Sci 33:e329. https://doi.org/10.3346/jkms.2018.33.e329
Eugster EA (2019) Update on precocious puberty in girls. J Pediatr Adolesc Gynecol 32:455–459. https://doi.org/10.1016/j.jpag.2019.05.011
Kerrigan JF, Ng Y, Chung S, Rekate HL (2005) The hypothalamic hamartoma: a model of subcortical epileptogenesis and encephalopathy. Semin Pediatr Neurol 12:119–131. https://doi.org/10.1016/j.spen.2005.04.002
Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group (2009) Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123:e752–e762. https://doi.org/10.1542/peds.2008-1783
Kim YJ, Kwon A, Jung MK, Kim KE, Suh J, Chae HW, Kim DH, Ha S, Seo GH, Kim HS (2019) Incidence and prevalence of central precocious puberty in Korea: an epidemiologic study based on a national database. J Pediatr 208:221–228. https://doi.org/10.1016/j.jpeds.2018.12.022
Boyce AM, Florenzano P, de Castro LF, Collins MT (1993) Fibrous dysplasia/McCune-Albright syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews Seattle (WA): University of Washington, Seattle [updated 2019 Jun 27].
Ghizzoni L, Gasco V (2010) Premature pubarche. Horm Res Paediatr 73:420–422. https://doi.org/10.1159/000308178
Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT (2012) Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab 97:E1782–E1790. https://doi.org/10.1210/jc.2012-1791
Stephen M, Zage P, Waguespack S (2011) Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations. Int J Pediatr Endocrinol 2011:184502. https://doi.org/10.1155/2011/184502
Brunner HG, Otten BJ (1999) Precocious puberty in boys. N Engl J Med 341:1763–1765. https://doi.org/10.1056/NEJM199912023412311
Schoelwer M, Eugster EA (2016) Treatment of peripheral precocious puberty. Endocr Dev 29:230–239. https://doi.org/10.1159/000438895
Urban MD, Lee PA, Plotnick LP, Migeon CJ (1978) The diagnosis of Leydig cell tumors in childhood. Am J Dis Child 132:494–497. https://doi.org/10.1001/archpedi.1978.02120300054011
Englund AT, Geffner ME, Nagel RA, Lippe BM, Braunstein GD (1991) Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features. Am J Dis Child 145:1294–1297. https://doi.org/10.1001/archpedi.1991.02160110086026
Hemady ZS, Siler-Khodr TM, Najjar S (1978) Precocious puberty in juvenile hypothyroidism. J Pediatr 92:55–59. https://doi.org/10.1016/s0022-3476(78)80070-5
Chrousos GP, Detera-Wadleigh SD, Karl M (1993) Syndromes of glucocorticoid resistance. Ann Intern Med 119:1113–1124. https://doi.org/10.7326/0003-4819-119-11-199312010-00009
Charmandari E, Kino T, Chrousos GP (2004) Familial/sporadic glucocorticoid resistance. Ann N Y Acad Sci 1024:168–181. https://doi.org/10.1196/annals.1321.014
Metwalley K, Farghaly H (2013) Aromatase excess syndrome presenting with prepubertal gynecomastia in an Egyptian child with type 1 neurofibromatosis. Indian J Hum Genet 19:472. https://doi.org/10.4103/0971-6866.124379
Stratakis CA, Vottero A, Brodie A, Kirschner LS, DeAtkine D, Lu Q, Yue W, Mitsiades CW, Flor AW, Chrousos GP (1998) The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription 1. J Clin Endocrinol Metab 83:1348–1357. https://doi.org/10.1210/jcem.83.4.4697
Starzyk J, Starzyk B, Bartnik-Mikuta A, Urbanowicz W, Dziatkowiak H (2001) Gonadotropin releasing hormone-independent precocious puberty in a 5 year-old girl with suprasellar germ cell tumor secreting β-hCG and α-fetoprotein. J Pediatr Endocrinol Metab 14:789–796. https://doi.org/10.1515/jpem.2001.14.6.789
Cornacchia MA, Bhushan S, Arguello R (2018) A case of familial male-limited precocious puberty in a child with Klinefelter syndrome. J Endocr Soc 2:1131–1136. https://doi.org/10.1210/js.2018-00192
Cabrera SM, DiMeglio LA, Eugster EA (2013) Incidence and characteristics of pseudoprecocious puberty because of severe primary hypothyroidism. J Pediatr 162:637–639. https://doi.org/10.1016/j.jpeds.2012.10.043
Zou CC, Liang L, Dong GP, Zhao ZY (2008) Peripheral precocious puberty: a retrospective study for six years in Hangzhou, China. J Paediatr Child Health 44:415–418. https://doi.org/10.1111/j.1440-1754.2008.01320.x
Ringel MD, Schwindinger WF, Levine MA (1996) Clinical implications of genetic defects in G proteins: the molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Med (Baltimore) 75:171–184. https://doi.org/10.1097/00005792-199607000-00001
Tanner JM, Goldstein H, Whitehouse RH (1970) Standards for children’s height at ages 2-9 years allowing for height of parents. Arch Dis Child 45:755–762. https://doi.org/10.1136/adc.45.244.755
Khokhar A, Mojica A (2018) Premature thelarche. Pediatr Ann 47:e12–e15. https://doi.org/10.3928/19382359-20171214-01
Bizzarri C, Spadoni GL, Bottaro G, Montanari G, Giannone G, Cappa M, Cianfarani S (2014) The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life. J Clin Endocrinol Metab 99:433–439. https://doi.org/10.1210/jc.2013-3292
Novello L, Speiser PW (2018) Premature adrenarche. Pediatr Ann 47:e7–e11. https://doi.org/10.3928/19382359-20171214-04
DeSalvo DJ, Mehra R, Vaidyanathan P, Kaplowitz PB (2013) In children with premature adrenarche, bone age advancement by 2 or more years is common and generally benign. J Pediatr Endocrinol Metab 26:215–221. https://doi.org/10.1515/jpem-2012-0283
Brito VN, Latronico AC, Arnhold IJP, Mendonça BB (2008) Update on the etiology, diagnosis and therapeutic management of sexual precocity. Arq Bras Endocrinol Metabol 52:18–31. https://doi.org/10.1590/s0004-27302008000100005
Haddad NG, Eugster EA (2019) Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes. Best Pract Res Clin Endocrinol Metab 33:101273. https://doi.org/10.1016/j.beem.2019.04.007
Corica D, Aversa T, Pepe G, De Luca F, Wasniewska M (2018) Peculiarities of precocious puberty in boys and girls with McCune-Albright syndrome. Front Endocrinol (Lausanne) 9:337. https://doi.org/10.3389/fendo.2018.00337
Neely EK, Hintz RL, Wilson DM, Lee PA, Gautier T, Argente J, Stene M (1995) Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr 127:40–46. https://doi.org/10.1016/s0022-3476(95)70254-7
Resende EAMR, Lara BHJ, Reis JD, Ferreira BP, Pereira GA, Borges MF (2007) Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children. J Clin Endocrinol Metab 92:1424–1429. https://doi.org/10.1210/jc.2006-1569
Houk CP, Kunselman AR, Lee PA (2009) Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls. Pediatrics 123:e1059–e1063. https://doi.org/10.1542/peds.2008-1180
Pasternak Y, Friger M, Loewenthal N, Haim A, Hershkovitz E (2012) The utility of basal serum LH in prediction of central precocious puberty in girls. Eur J Endocrinol 166:295–299. https://doi.org/10.1530/EJE-11-0720
Lee DS, Ryoo NY, Lee SH, Kim S, Kim JH (2013) Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls? Ann Pediatr Endocrinol Metab 18:196–201. https://doi.org/10.6065/apem.2013.18.4.196
Brito VN, Batista MC, Borges MF, Latronico AC, Kohek MB, Thirone AC, Jorge BH, Arnhold IJ, Mendonca BB (1999) Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 84:3539–3544. https://doi.org/10.1210/jcem.84.10.6024
Kaplowitz PB (2020) For premature thelarche and premature adrenarche, the case for waiting before testing. Horm Res Paediatr:1–4. https://doi.org/10.1159/000512764
Kaplowitz P, Bloch C (2016) Evaluation and referral of children with signs of early puberty. Pediatrics 137(1):e20153732. https://doi.org/10.1542/peds.2015-3732
Potau N, Ibáñez L, Sentis M, Carrascosa A (1999) Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge. Eur J Endocrinol 141:27–34. https://doi.org/10.1530/eje.0.1410027
Shaw ND, Butler JP, McKinney SM, Nelson SA, Ellenbogen JM, Hall JE (2012) Insights into puberty: the relationship between sleep stages and pulsatile LH secretion. J Clin Endocrinol Metab 97:1–8. https://doi.org/10.1210/jc.2012-2692
Fuqua JS (2013) Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab 98:2198–2207. https://doi.org/10.1210/jc.2013-1024
Sathasivam A, Garibaldi L, Shapiro S, Godbold J, Rapaport R (2010) Leuprolide stimulation testing for the evaluation of early female sexual maturation. Clin Endocrinol (Oxf) 73:375–381. https://doi.org/10.1111/j.1365-2265.2010.03796.x
Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB Jr (1988) Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 67:474–479. https://doi.org/10.1210/jcem-67-3-474
Soriano-Guillén L, Argente J (2011) Pubertad precoz central: aspectos epidemiológicos, etiológicos y diagnóstico-terapéuticos. An Pediatría 74:336.e1–336.e13. https://doi.org/10.1016/j.anpedi.2010.11.003
Partsch CJ, Heger S, Sippell WG (2002) Management and outcome of central precocious puberty. Clin Endocrinol (Oxf) 56:129–148. https://doi.org/10.1046/j.0300-0664.2001.01490.x
Sørensen K, Aksglaede L, Petersen JH, Andersson AM, Juul A (2012) Serum IGF1 and insulin levels in girls with normal and precocious puberty. Eur J Endocrinol 166:903–910. https://doi.org/10.1530/EJE-12-0106
Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford, CA, USA
Tanner JM, Healy MJR, Cameron N, Goldstein H (2001) Assessment of skeletal maturity and prediction of adult height (TW3 method). London: W.B. Saunders.
Prokop-Piotrkowska M, Marszałek-Dziuba K, Moszczyńska E, Szalecki M, Jurkiewicz E (2020) Traditional and new methods of bone age assessment - an overview. J Clin Res Pediatr Endocrinol. 0:0. https://doi.org/10.4274/jcrpe.galenos.2020.2020.0091
Melmed S, Koenig R, Rosen C, Auchus R, Goldfine A (2016). Williams textbook of endocrinology, 14th ed. Elselvier.
Bar A, Linder B, Sobel EH, Saenger P, DiMartino-Nardi J (1995) Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr 126:955–958. https://doi.org/10.1016/s0022-3476(95)70221-0
Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Santos MG, Bianco SDC, Kuohung W, Xu S, Gryngarten M, Escobar ME, Arnhold IJP, Mendonca BB, Kaiser UB, Latronico AC (2010) Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab 95:2276–2280. https://doi.org/10.1210/jc.2009-2421
Carel JC, Lahlou N, Roger M, Chaussain JL (2004) Precocious puberty and statural growth. Hum Reprod Update 10:135–147. https://doi.org/10.1093/humupd/dmh012
Brito VN, Latronico AC, Cukier P, Cukier P, Teles MG, Silveira LFG, Arnhold IJP, Mendonca BB (2008) Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab 93:2662–2669. https://doi.org/10.1210/jc.2007-2183
Cantas-Orsdemir S, Garb JL, Allen HF (2018) Prevalence of cranial MRI findings in girls with central precocious puberty: a systematic review and meta-analysis. J Pediatr Endocrinol Metab 31:701–710. https://doi.org/10.1515/jpem-2018-0052
Mogensen SS, Aksglaede L, Mouritsen A, Sørensen K, Main KM, Gideon P, Juul A (2012) Pathological and incidental findings on brain MRI in a single-center study of 229 consecutive girls with early or precocious puberty. PLoS One 7:e29829. https://doi.org/10.1371/journal.pone.0029829
Ziereisen F, Guissard G, Damry N, Avni EF (2005) Sonographic imaging of the paediatric female pelvis. Eur Radiol 15:1296–1309. https://doi.org/10.1007/s00330-005-2648-6
de Vries L, Phillip M (2011) Role of pelvic ultrasound in girls with precocious puberty. Horm Res Paediatr 75:148–152. https://doi.org/10.1159/000323361
Wen X, Wen D, Zhang H, Zhang H, Yang Y (2018) Observational study pelvic ultrasound a useful tool in the diagnosis and differentiation of precocious puberty in Chinese girls. Med (Baltimore) 97:e0092. https://doi.org/10.1097/MD.0000000000010092
Binay C, Simsek E, Bal C (2014) The correlation between GnRH stimulation testing and obstetric ultrasonographic parameters in precocious puberty. J Pediatr Endocrinol Metab 27:1193–1199. https://doi.org/10.1515/jpem-2013-0363
Kılıç A, Durmuş MS, Ünüvar E, Yıldız I, Aydın BK, Uçar A, Bundak R, Baş F, Darendeliler F, Oğuz F et al (2012) Clinical and laboratory characteristics of children referred for early puberty: preponderance in 7-8 years of age. J Clin Res Pediatr Endocrinol 4:208–212. https://doi.org/10.4274/jcrpe.736
Lee SH, Joo EY, Lee JE, Jun YH, Kim MY (2016) The diagnostic value of pelvic ultrasound in girls with central precocious puberty. Chonnam Med J 52:70–74. https://doi.org/10.4068/cmj.2016.52.1.70
Yu J, Shin HY, Lee SH, Kim YS, Kim JH (2015) Usefulness of pelvic ultrasonography for the diagnosis of central precocious puberty in girls. Korean J Pediatr 58:294–300. https://doi.org/10.3345/kjp.2015.58.8.294
Eksioglu AS, Yilmaz S, Cetinkaya S, Cinar G, Yildiz YT, Aycan Z (2013) Value of pelvic sonography in the diagnosis of various forms of precocious puberty in girls. J Clin Ultrasound 41:84–93. https://doi.org/10.1002/jcu.22004
Long MG, Boultbee JE, Hanson ME, Begent RHJ (1989) Doppler time velocity waveform studies of the uterine artery and uterus. Br J Obstet Gynaecol 96:588–593. https://doi.org/10.1111/j.1471-0528.1989.tb03261.x
Laursen EM, Holm K, Brocks V, Jarden M, Müller J (1996) Doppler assessment of flow velocity in the uterine artery during pubertal maturation. Ultrasound Obstet Gynecol 8:341–345. https://doi.org/10.1046/j.1469-0705.1996.08050341.x
Ziereisen F, Heinrichs C, Dufour D, Saerens M, Avni EF (2001) The role of Doppler evaluation of the uterine artery in girls around puberty. Pediatr Radiol 31:712–719. https://doi.org/10.1007/s002470100463
Battaglia C, Mancini F, Regnani G, Persico N, Iughetti L, De Aloysio D (2003) Pelvic ultrasound and color Doppler findings in different isosexual precocities. Ultrasound Obstet Gynecol 22:277–283. https://doi.org/10.1002/uog.154
Paesano PL, Colantoni C, Mora S, di Lascio A, Ferrario M, Esposito A, Ambrosi A, Maschio AD, Russo G (2019) Validation of an accurate and noninvasive tool to exclude female precocious puberty: pelvic ultrasound with uterine artery pulsatility index. AJR Am J Roentgenol 213:451–457. https://doi.org/10.2214/AJR.18.19875
de Vries L, Kauschansky A, Shohat M, Phillip M (2004) Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab 89:1794–1800. https://doi.org/10.1210/jc.2003-030361
Canton APM, Seraphim CE, Brito VN, Latronico AC (2019) Pioneering studies on monogenic central precocious puberty. Arch. Endocrinol Metab 63:438–444. https://doi.org/10.20945/2359-3997000000164
Macedo DB, Abreu AP, Reis ACS, Montenegro LR, Daber A, Beneduzzi D, Cukier P, Silveira LFG, Teles MG, Carroll RS et al (2014) Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene Makorin Ring Finger 3. J Clin Endocrinol Metab 99:E1097–E1103. https://doi.org/10.1210/jc.2013-3126
Bessa DS, Macedo DB, Brito VN, França MM, Montenegro LR, Cunha-Silva M, Silveira LG, Hummel T, Bergadá I, Braslavskyet D et al (2017) High frequency of MKRN3 mutations in male central precocious puberty previously classified as idiopathic. Neuroendocrinology 105:17–25. https://doi.org/10.1159/000446963
Simon D, Ba I, Mekhail N, Ecosse E, Paulsen A, Zenaty D, Houang M, Perelroizen MJ, de Filippo GP, Salerno M et al (2016) Mutations in the maternally imprinted gene MKRN3 are common in familial central precocious puberty. Eur J Endocrinol 174:1–8. https://doi.org/10.1530/EJE-15-0488
Lee H, Jin HS, Shim Y, Jeong HR, Kwon E, Choi V, Kim MC, Chung IS, Jeong SY, Hwang JS (2016) Low frequency of MKRN3 mutations in central precocious puberty among Korean girls. Horm Metab Res 48:118–122. https://doi.org/10.1055/s-0035-1548938
Ortiz-Cabrera NV, Riveiro-Álvarez R, López-Martínez MA, Pérez-Segura P, Aragón-Gómez I, Trujillo-Tiebas MJ, Soriano-Guillén L (2017) Clinical exome sequencing reveals MKRN3 pathogenic variants in familial and nonfamilial idiopathic central precocious puberty. Horm Res Paediatr 87:88–94. https://doi.org/10.1159/000453262
Valadares LP, Meireles CG, De Toledo IP, Oliveira RS, Castro LCG, Abreu AP, Carroll RS, Latronico AC, Kaiser UB, Guerra ENS et al (2019) MKRN3 mutations in central precocious puberty: a systematic review and meta-analysis. J Endocr Soc 3:979–995. https://doi.org/10.1210/js.2019-00041
Abreu AP, Dauber A, Macedo DB, Noel SD, Brito VN, Gill JC, Cukier P, Thompson IR, Navarro VM, Gagliardi PC, Rodrigues T, Kochi C, Longui CA, Beckers D, de Zegher F, Montenegro LR, Mendonca BB, Carroll RS, Hirschhorn JN, Latronico AC, Kaiser UB (2013) Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med 368:2467–2475. https://doi.org/10.1056/NEJMoa1302160
Schmidt JV, Matteson PG, Jones BK, Guan XJ, Tilghman S (2000) The DLK1 and GTL2 genes are linked and reciprocally imprinted. Genes Dev 14:1997–2002
Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E (1978) Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science 202:631–633. https://doi.org/10.1126/science.100883
Eugster EA (2019) Treatment of central precocious puberty. J Endocr Soc 3:965–972. https://doi.org/10.1210/js.2019-00036
Cook JS, Doty KL, Conn PM, Hansen JR (1992) Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty. J Clin Endocrinol Metab 74:1206–1209. https://doi.org/10.1210/jcem.74.5.1569169
Guaraldi F, Beccuti G, Gori D, Ghizzoni L (2016) Management of endocrine disease: long-term outcomes of the treatment of central precocious puberty. Eur J Endocrinol 174(3):R79–R87. https://doi.org/10.1530/EJE-15-0590
Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwé C, Jansen M, Gerver WJ, Waelkens J, Drop S (1996) Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 75:292–297. https://doi.org/10.1136/adc.75.4.292
Klein KO, Freire A, Gryngarten MG, Kletter GB, Benson M, Miller BS, Dajani TS, Eugster EA, Mauras N (2020) Phase 3 trial of a small-volume subcutaneous 6-month duration leuprolide acetate treatment for central precocious puberty. J Clin Endocrinol Metab 105:e3660–e3671. https://doi.org/10.1210/clinem/dgaa479
Lewis KA, Goldyn AK, West KW, Eugster EA (2013) A single histrelin implant is effective for 2 years for treatment of central precocious puberty. J Pediatr 163:1214–1216. https://doi.org/10.1016/j.jpeds.2013.05.033
Bereket A (2017) A critical appraisal of the effect of gonadotropin-releasing hormon analog treatment on adult height of girls with central precocious puberty. J Clin Res Pediatr Endocrinol 9:33–48. https://doi.org/10.4274/jcrpe.2017.S004
Lazar L, Padoa A, Phillip M (2007) Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity. J Clin Endocrinol Metab 92:3483–3489. https://doi.org/10.1210/jc.2007-0321
Kaplowitz PB, Backeljauw PF, Allen DB (2018) Toward more targeted and cost-effective gonadotropin-releasing hormone analog treatment in girls with central precocious puberty. Horm Res Paediatr 90:1–7. https://doi.org/10.1159/000491103
Bertelloni S, Massart F, Miccoli M, Baroncelli GI (2017) Adult height after spontaneous pubertal growth or GnRH analog treatment in girls with early puberty: a meta-analysis. Eur J Pediatr 176:697–704. https://doi.org/10.1007/s00431-017-2898-8
Shim YS, Lim KI, Lee HS, Hwang JS (2020) Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty. PLoS One 15:e0243212. https://doi.org/10.1371/journal.pone.0243212
Toro CA, Aylwin CF, Lomniczi A (2018) Hypothalamic epigenetics driving female puberty. J Neuroendocrinol 30:e12589. https://doi.org/10.1111/jne.12589
Carel JC, Lahlou N, Jaramillo O, Montauban V, Teinturier C, Colle M, Lucas C, Chaussain JL (2002) Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg). J Clin Endocrinol Metab 87:4111–4116. https://doi.org/10.1210/jc.2001-020243
Johnson SR, Nolan RC, Grant MT, Price GJ, Siafarikas A, Bint L, Choong CS (2012) Sterile abscess formation associated with depot leuprorelin acetate therapy for central precocious puberty. J Paediatr Child Health 48:E136–E139. https://doi.org/10.1111/j.1440-1754.2011.02083.x
Park J, Kim JH (2017) Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty. Ann Pediatr Endocrinol Metab 22:27–35. https://doi.org/10.6065/apem.2017.22.1.27
Yang WJ, Ko KH, Lee KH, Hwang IT, Oh YJ (2017) The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty. Ann Pediatr Endocrinol Metab 22:49–54. https://doi.org/10.6065/apem.2017.22.1.49
Censani M, Feuer A, Orton S, Askin G, Vogiatzi M (2019) Changes in body mass index in children on gonadotropin-releasing hormone agonist therapy with precocious puberty, early puberty or short stature. J Pediatr Endocrinol Metab 32:1065–1070. https://doi.org/10.1515/jpem-2019-0105
Lee SJ, Yang EM, Seo JY, Kim CJ (2012) Effects of gonadotropin-releasing hormone agonist therapy on body mass index and height in girls with central precocious puberty. Chonnam Med J 48:27–31. https://doi.org/10.4068/cmj.2012.48.1.27
Eugster EA, Clarke W, Kletter GB, Lee PA, Neely EK, Reiter EO, Saenger P, Shulman D, Silverman L, Flood L, Gray W, Tierney D (2007) Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial. J Clin Endocrinol Metab 92:1697–1704. https://doi.org/10.1210/jc.2006-2479
Bangalore Krishna K, Fuqua JS, Rogol AD, Klein KO, Popovic J, Houk CP, Charmandari E, Lee PA, Freire AV, Ropelato MG, Yazid Jalaludin M, Mbogo J, Kanaka-Gantenbein C, Luo X, Eugster EA, Klein KO, Vogiatzi MG, Reifschneider K, Bamba V, Garcia Rudaz C, Kaplowitz P, Backeljauw P, Allen DB, Palmert MR, Harrington J, Guerra-Junior G, Stanley T, Torres Tamayo M, Miranda Lora AL, Bajpai A, Silverman LA, Miller BS, Dayal A, Horikawa R, Oberfield S, Rogol AD, Tajima T, Popovic J, Witchel SF, Rosenthal SM, Finlayson C, Hannema SE, Castilla-Peon MF, Mericq V, Medina Bravo PG (2019) Use of gonadotropin-releasing hormone analogs in children: update by an international consortium. Horm Res Paediatr 91:357–372. https://doi.org/10.1159/000501336
Neely EK, Silverman LA, Geffner ME, Danoff TM, Gould E, Thornton PS (2013) Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy. Int J Pediatr Endocrinol 2013:20. https://doi.org/10.1186/1687-9856-2013-20
Badaru A, Wilson DM, Bachrach LK, Fechner P, Gandrud LM, Durham E, Wintergerst K, Chi C, Klein KO, Neely EK (2006) Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty. J Clin Endocrinol Metab 91:1862–1867. https://doi.org/10.1210/jc.2005-1500
Acharya SV, Gopal RA, George J, Bandgar TR, Menon PS, Shah NS (2009) Utility of single luteinizing hormone determination 3 h after depot leuprolide in monitoring therapy of gonadotropin-dependent precocious puberty. Pituitary 12:335–338. https://doi.org/10.1007/s11102-009-0184-0
Demirbilek H, Alikasifoglu A, Gonc NE, Ozon A, Kandemir N (2012) Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection. Clin Endocrinol (Oxf) 76:126–130. https://doi.org/10.1111/j.1365-2265.2011.04185.x
Yüce Ö, Bideci A, Çelik N, Çamurdan O, Cinaz P (2020) Diagnostic value of urinary luteinizing hormone levels in the monitoring of precocious puberty treatment. Arch. Endocrinol Metab 64:121–127. https://doi.org/10.20945/2359-3997000000212
Lim YY, Chan RM, Loke KY, Ho CW, Lee YS (2014) Familial male-limited precocious puberty in neurofibromatosis type I. Eur J Pediatr 173:219–222. https://doi.org/10.1007/s00431-013-2141-1
Almeida MQ, Brito VN, Lins TSS, Guerra-Junior G, Castro M, Antonini SR, Arnhold IJP, Mendonca BB, Latronico AC (2008) Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clin Endocrinol (Oxf) 69:93–98. https://doi.org/10.1111/j.1365-2265.2007.03160.x
Agopiantz M, Journeau P, Lebon-Labich B, Sorlin A, Cuny T, Weryha G, Leheup B (2016) McCune-Albright syndrome, natural history and multidisciplinary management in a series of 14 pediatric cases. Ann Endocrinol (Paris) 77:7–13. https://doi.org/10.1016/j.ando.2016.01.002
Estrada A, Boyce AM, Brillante BA, Guthrie LC, Gafni RI, Collins MT (2016) Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune–Albright syndrome. Eur J Endocrinol 75:477–483. https://doi.org/10.1530/EJE-16-0526
Livadas S, Bothou C (2019) Management of the female with non-classical congenital adrenal hyperplasia (NCCAH): a patient-oriented approach. Front Endocrinol (Lausanne) 10:366. https://doi.org/10.3389/fendo.2019.00366
Sharma B, Singh H, Saran S, Mathur S (2017) Primary hypothyroidism presenting as a pituitary macroadenoma and precocious puberty. Thyroid Res Pract 14:81–85. https://doi.org/10.4103/trp.trp_6_17
Ramos CO, Macedo DB, Bachega TASS, Nascimento ML, Madureira G, Latronico AC, Brito VN, Mendonca BB (2019) Premature pubarche due to exogenous testosterone gel or intense diaper rash prevention cream use: a case series. Horm Res Paediatr 91:411–415. https://doi.org/10.1159/000495664
Eugster EA, Rubin SD, Reiter EO, Plourde P, Jou HC, Pescovitz OH (2003) Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr 143:60–66. https://doi.org/10.1016/S0022-3476(03)00128-8
Alonso LC, Rosenfield RL (2002) Oestrogens and puberty. Best Pract Res Clin Endocrinol Metab 16:13–30. https://doi.org/10.1053/beem.2002.0177
Feuillan P, Calis K, Hill S, Shawker T, Robey PG (2007) Collins MT (2007) Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. J Clin Endocrinol Metab 92:2100–2106. https://doi.org/10.1210/jc.2006-2350
White PC (2018) Update on diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Curr Opin Endocrinol Diabetes Obes 25:178–184. https://doi.org/10.1097/MED.0000000000000402
Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, Arundel P, Shaw N, Pos VD, Underhil A, Portero D, Heral L, Heegaard AM, Masi L, Monsell F, Stanton R, Dijkstra PDS, Brandi ML, Chapurlat R, Hamdy NAT, Collins MT (2019) Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis 14:139. https://doi.org/10.1186/s13023-019-1102-9
Leschek EW, Flor AC, Bryant JC, Jones JV, Barnes KM, Cutler GB Jr (2017) Effect of antiandrogen, aromatase inhibitor, and gonadotropin-releasing hormone analog on adult height in familial male precocious puberty. J Pediatr 190:229–235. https://doi.org/10.1016/j.jpeds.2017.07.047
Leschek EW, Jones J, Barnes KM, Hill SC, Cutler GB Jr (1999) Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset. J Clin Endocrinol Metab 84:175–178. https://doi.org/10.1210/jcem.84.1.5413